More on AUPH
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $16.79 |
|
|||
| Open | $16.88 | ||||
| 52 Wk High | $5.69 | ||||
| 52 Wk Low | $1.42 | ||||
| Day High | $17.27 | ||||
| Day Low | $16.87 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 2,033,222 | ||||
- Form 4 Aurinia Pharmaceuticals For: Jun 04 Filed by: Johnson Craig A
- Form 4 Aurinia Pharmaceuticals For: Jun 04 Filed by: Goetz Kathleen
- Form 4 Aurinia Pharmaceuticals For: Jun 04 Filed by: Nova Tina Susan
- Form 4 Aurinia Pharmaceuticals For: Jun 04 Filed by: Bailey Jeffrey Allen
- Form 144 Aurinia Pharmaceuticals Filed by: Keenan Greg
- Form SCHEDULE 13D/A Aurinia Pharmaceuticals Filed by: TANG CAPITAL MANAGEMENT LLC
- Form 8-K Aurinia Pharmaceuticals For: Jun 03
- Form 144 Aurinia Pharmaceuticals Filed by: Keenan Greg
- LUPKYNIS Associated with a Statistically Significant 53% Reduction in Risk of Renal-Related Event or Death
- Form 4 Aurinia Pharmaceuticals For: May 29 Filed by: TANG KEVIN
Entities mentioned with AUPH
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Definitive Agreement | View Related Stories »
- H.C. Wainwright | View Related Stories »
- Jefferies & Co | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Show More...
